Clinical Trials in North Carolina

Showing 781-800 of 20,428 trials

Perceptions of Proposed Warnings for Cannabis Edibles Packaging

NCT07496489

The purpose of this study is to compare a delayed-effects warning to an expanded warning developed in previous experiments on knowledge, harm perceptions, and willingness to try cannabis edibles. Additionally, this study will examine the effects of a corresponding icon on attention to and recall of the warning.

Cannabis Use

Wake Forest University Health Sciences1,250 participantsStarted Jun 2026

Winston-Salem, North Carolina, United States

Enrolling By InvitationPhase 341 miles

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

NCT07008469

A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1

Myotonic Dystrophy Type 1DM1Myotonic Dystrophy+5 more

Avidity Biosciences, Inc.230 participantsStarted Jul 2025

Los Angeles, California, United States • Stanford, California, United States • Denver, Colorado, United States +23 more locations

Perceptions of Proposed Warnings for Cannabis Edibles Packaging

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

Find Trials by Condition in North Carolina

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Pyruvate Kinase Deficiency Global Longitudinal Registry

Prebiotic Galacto-oligosaccharide and Acute GVHD

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

Assessing How Normal Variations in CT Scanning Affects Its Interpretation